Clinical Trials Arena on MSN
Novocure’s Optune Gio fails to show benefit at earlier stage
The Phase III TRIDENT study failed to show statistical significance in OS when Optune Gio was used earlier.
Gleolan, a dye used for brain imaging, can help surgeons visualize tumor tissue during surgery for glioblastoma multiforme. Malignant transformation occurs from aggregation of genetic alterations and ...
A Bay Area cancer patient is making more memories and living longer than his initial diagnosis thanks to a groundbreaking ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted orphan drug designation to WP1122 for the treatment of glioblastoma multiforme, according to a ...
A study led by Nicolas Bazan, MD, Ph.D., Boyd Professor and Director of LSU Health New Orleans Neuroscience Center of Excellence, reports that in an experimental model of glioblastoma multiforme (GBM) ...
Patients’ experience and physicians strategies for selection of anthracyclines and taxanes sequential treatment in adjuvant breast cancer: The Violayne prospective multicenter survey. Efficacy of ...
Scientists at the Fralin Biomedical Research Institute at VTC have identified a new zebrafish model that could help advance glioblastoma multiforme research. Glioblastoma is an aggressive form of ...
NeOnc Technologies Advances Novel Neuro-Oncology Therapies Targeting Glioblastoma and Other Hard-to-Treat Brain CancersHouston, Texas--(Newsfile Corp. - June 9, 2026) - For years, artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results